ATE210678T1 - Äusseres hauptmembranprotein cd von moraxella - Google Patents

Äusseres hauptmembranprotein cd von moraxella

Info

Publication number
ATE210678T1
ATE210678T1 AT95944810T AT95944810T ATE210678T1 AT E210678 T1 ATE210678 T1 AT E210678T1 AT 95944810 T AT95944810 T AT 95944810T AT 95944810 T AT95944810 T AT 95944810T AT E210678 T1 ATE210678 T1 AT E210678T1
Authority
AT
Austria
Prior art keywords
protein
pellet
remaining
bacterial
proteins
Prior art date
Application number
AT95944810T
Other languages
English (en)
Inventor
Yan-Ping Yang
Robin E Harkness
Lisa E Myers
Ursula Mcguinness
Michel H Klein
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23281593&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE210678(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Application granted granted Critical
Publication of ATE210678T1 publication Critical patent/ATE210678T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95944810T 1994-10-24 1995-10-23 Äusseres hauptmembranprotein cd von moraxella ATE210678T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32858994A 1994-10-24 1994-10-24
PCT/CA1995/000604 WO1996012733A1 (en) 1994-10-24 1995-10-23 Major outer membrane protein cd of moraxella

Publications (1)

Publication Number Publication Date
ATE210678T1 true ATE210678T1 (de) 2001-12-15

Family

ID=23281593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95944810T ATE210678T1 (de) 1994-10-24 1995-10-23 Äusseres hauptmembranprotein cd von moraxella

Country Status (14)

Country Link
US (1) US6121427A (de)
EP (1) EP0787144B1 (de)
JP (1) JP3534771B2 (de)
CN (1) CN1161376C (de)
AT (1) ATE210678T1 (de)
AU (1) AU706832B2 (de)
CA (1) CA2203540C (de)
DE (1) DE69524626T2 (de)
DK (1) DK0787144T3 (de)
ES (1) ES2169166T3 (de)
MX (1) MX9702952A (de)
PT (1) PT787144E (de)
RU (1) RU2186582C2 (de)
WO (1) WO1996012733A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335018B1 (en) * 1995-05-01 2002-01-01 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella
EP0918858A1 (de) 1996-05-10 1999-06-02 Biogen, Inc. Agenzien, die die gemeinsame gamma-kette blockieren
US5977337A (en) 1997-06-03 1999-11-02 Connaught Laboratories Limited Lactoferrin receptor genes of Moraxella
US7105164B1 (en) 1998-04-07 2006-09-12 Sanofi Pasteur Limited HIV-specific cytotoxic T-cell responses
GB9808720D0 (en) 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
GB9810084D0 (en) * 1998-05-11 1998-07-08 Cortecs Uk Ltd Proteins
US6541616B1 (en) * 1998-10-01 2003-04-01 Antex Biologics Inc. Moraxella catarrhalis protein, gene sequence and uses thereof
AU5292300A (en) * 1999-05-24 2000-12-12 Xoma (Us) Llc Therapeutic uses of bpi protein products in humans with otitis media with effusion
US7517968B2 (en) * 2003-07-07 2009-04-14 Syracuse University Rapid and inexpensive method for the purification of proteorhodopsin
RU2601158C1 (ru) * 2015-05-12 2016-10-27 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) ШТАММЫ ВИДА Streptococcus pneumoniae (ВАРИАНТЫ) И СПОСОБ ПОЛУЧЕНИЯ ИЗ НИХ ПРОТЕКТИВНОЙ БЕЛОКСОДЕРЖАЩЕЙ ФРАКЦИИ, ОБЛАДАЮЩЕЙ ВНУТРИВИДОВОЙ ИММУНОГЕННОЙ АКТИВНОСТЬЮ

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
US5110908A (en) * 1986-12-31 1992-05-05 Praxis Biologics, Inc. Haemophilus influenzae peptides and proteins
DE3715840A1 (de) * 1987-05-12 1988-12-01 Boehringer Mannheim Gmbh Fuer ein lytisch wirksames, chimaeres protein kodierende rekombinante dna und ihre verwendung
US5393658A (en) * 1987-09-28 1995-02-28 New Horizons Diagnostics Corporation Immunoassay method for the rapid identification of detergent treated antigens
ATE108557T1 (de) * 1989-04-14 1994-07-15 Unilever Nv Extraktionsverfahren.
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
US5552146A (en) * 1991-08-15 1996-09-03 Board Of Regents, The University Of Texas System Methods and compositions relating to useful antigens of Moraxella catarrhalis
ES2145072T3 (es) * 1993-05-13 2000-07-01 American Cyanamid Co Preparacion y usos de proteinas de membranas externas carentes de los de cocos gramnegativos.
IL111102A0 (en) * 1993-09-29 1994-11-28 Univ New York State Res Found Vaccine for branhamella catarrhalis
US5712118A (en) * 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis

Also Published As

Publication number Publication date
PT787144E (pt) 2002-06-28
AU3695395A (en) 1996-05-15
WO1996012733A1 (en) 1996-05-02
MX9702952A (es) 1997-06-28
CA2203540A1 (en) 1996-05-02
EP0787144A1 (de) 1997-08-06
CN1161376C (zh) 2004-08-11
CN1174559A (zh) 1998-02-25
DK0787144T3 (da) 2002-01-14
CA2203540C (en) 2005-04-05
DE69524626T2 (de) 2002-07-04
RU2186582C2 (ru) 2002-08-10
HK1009453A1 (en) 1999-09-17
DE69524626D1 (de) 2002-01-24
JP3534771B2 (ja) 2004-06-07
JPH10508303A (ja) 1998-08-18
EP0787144B1 (de) 2001-12-12
ES2169166T3 (es) 2002-07-01
US6121427A (en) 2000-09-19
AU706832B2 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
MX9708438A (es) Proteina principal de la membrana externa de moraxella, de alto peso molecular.
Domont et al. Natural anti-snake venom proteins
ATE229979T1 (de) Transferrinrezeptor protein aus moraxella
ATE210678T1 (de) Äusseres hauptmembranprotein cd von moraxella
Geren et al. Isolation and characterization of toxins from brown recluse spider venom (Loxosceles reclusa)
Omori-Satoh et al. The antihemorrhagic factor, erinacin, from the European hedgehog (Erinaceus europaeus), a metalloprotease inhibitor of large molecular size possessing ficolin/opsonin P35 lectin domains
Slomiany et al. Mucus glycoprotein of human saliva: differences in the associated and covalently bound lipids with caries
AU1463097A (en) Helicobacter pylori bacterioferritin
AU2529095A (en) Vaccine against mycobacterial infections
Faust et al. Degradation of the parasporal crystal produced by Bacillus thuringiensis var. kurstaki
Ouazana et al. Biochemical characterization of the cuticle collagen of the nematode Caenorhabditis elegans
Kemparaju et al. Purification of a basic phospholipase A2 from Indian saw-scaled viper (Echis carinatus) venom: characterization of antigenic, catalytic and pharmacological properties
DK172329B1 (da) Polydisperse, native Pseudomonas-flagella(H)-antigener (FAg) i polymer form og fremgangsmåde til deres udvinding
Lowy et al. Polypeptides minimine and melittin from bee venom: effects on Drosophila
Bernheimer et al. Toxins of the sea anemone Epiactis prolifera
ES2171563T3 (es) Nueva familia de inhibidores de proteasas, y otras sustancias de actividad biologica.
US5084561A (en) Method for the purification of a 168 kd protein from mycoplasma pneumoniae
AU5573196A (en) A pluripotent vaccine against enveloped viruses
Ryan et al. Major hemolymph proteins from larvae of the black swallowtail butterfly, Papilio polyxenes
McCrone Spider venoms: biochemical aspects
Treadwell et al. Purification of the ‘link proteins’ from bovine articular cartilage and comparison with ‘link proteins’ from nasal septum
Koga et al. Composition of major outer membrane proteins of Vibrio vulnificus isolates: effect of different growth media and iron deficiency
DK1005487T3 (da) Ydre 74 kD-membranprotein fra Moraxella catarrhalis
Mountford et al. Fractionation of schistosome antigens by high performance electrophoretic chromatography and their screening for the ability to induce Th1 lymphocyte activity
Procházka et al. The antigenic structure of Francisella tularensis: II. Fractionation of the ether antigen on cellulose carriers and by gel filtration